Higher serum testosterone is associated with increased risk of advanced hepatitis C–related liver disease in males

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Hepatology

• Publication date

  2012-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/hep.24618PMID 21858849PMCID PMC3399504
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The impact of body mass index on semen parameters and reproductive hormones in human males: a systematic review with meta-analysis.

  2010cited by this paper
• Evaluation of semen variables, sperm chromosomal abnormalities and reproductive endocrine profile in patients with chronic hepatitis C

  2010cited by this paper
• Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome.

  2010cited by this paper
• Androgen Receptor Promotes Hepatitis B Virus–Induced Hepatocarcinogenesis Through Modulation of Hepatitis B Virus RNA Transcription

  2010cited by this paper
• ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measure.

  2010cited by this paper
• An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa‐2b combination therapy for chronic hepatitis C

  2009cited by this paper
• Identification of androgen response elements in the enhancer I of hepatitis B virus: A mechanism for sex disparity in chronic hepatitis B

  2009cited by this paper
• Laboratory measurement of testosterone.

  2009cited by this paper
• Hepatitis B virus X protein enhances the transcriptional activity of the androgen receptor through c‐Src and glycogen synthase kinase‐3β kinase pathways

  2009cited by this paper
• Estimation of stage‐specific fibrosis progression rates in chronic hepatitis C virus infection: A meta‐analysis and meta‐regression

  2008cited by this paper
• Hepatitis C Virus Core Protein Augments Androgen Receptor-Mediated Signaling

  2008cited by this paper
• Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level

  2007cited by this paper
• Fibrotest-Actitest: the biochemical marker of liver fibrosis--the Israeli experience.

  2007cited by this paper
• The FibroTest value in discriminating between insignificant and significant fibrosis in chronic hepatitis C patients. The Romanian experience.

  2007cited by this paper
• Enhancement of gene transactivation activity of androgen receptor by hepatitis B virus X protein.

  2007cited by this paper
• Comments on: Panel data analysis—advantages and challenges

  2007cited by this paper
• Independent Prospective Multicenter Validation of Biochemical Markers (Fibrotest–Actitest) for the Prediction of Liver Fibrosis and Activity in Patients with Chronic Hepatitis C: The Fibropaca Study

  2006cited by this paper
• Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis.

  2006cited by this paper
• Chronic hepatitis C infection and sex hormone levels: effect of disease severity and recombinant interferon‐α therapy

  2006cited by this paper
• The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002

  2006cited by this paper
• Chronic hepatitis C infection and sex hormone levels: effect of disease severity and recombinant interferon-alpha therapy.

  2006cited by this paper
• Elevated prevalence of hepatitis C infection in users of United States veterans medical centers

  2005cited by this paper
• Accuracy of eight-polar bioelectrical impedance analysis for the assessment of total and appendicular body composition in peritoneal dialysis patients

  2005cited by this paper
• Prospective Multicenter Study of Eligibility for Antiviral Therapy Among 4,084 U.S. Veterans with Chronic Hepatitis C Virus Infection

  2005cited by this paper
• Hepatocellular carcinoma in cirrhosis: incidence and risk factors.

  2004cited by this paper
• Comparison of different methods for the measurement of serum testosterone in the aging male.

  2004cited by this paper
• Androgens and liver tumors: Fanconi's anemia and non‐Fanconi's conditions

  2004cited by this paper
• Cross-calibration of eight-polar bioelectrical impedance analysis versus dual-energy X-ray absorptiometry for the assessment of total and appendicular body composition in healthy subjects aged 21-82 years

  2003cited by this paper
• Associations of total energy and macronutrients with colon cancer risk in African Americans and Whites: results from the North Carolina colon cancer study.

  2003cited by this paper
• Report of the First International Liver Transplantation Society Expert Panel Consensus Conference on Liver Transplantation and Hepatitis C

  2003cited by this paper
• Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial

  2002cited by this paper
• Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men.

  2001influential reference
• The ABCs of hepatitis

  2000cited by this paper
• Serum testosterone:estradiol ratio and the development of hepatocellular carcinoma among male cirrhotic patients.

  2000cited by this paper
• Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma.

  2000influential reference
• Prevalence of hepatitis C virus infection in the United States.

  1999cited by this paper
• Sex hormone-binding globulin in non-cirrhotic alcoholic patients during early withdrawal and after longer abstinence.

  1999cited by this paper
• Gastric adenocarcinoma and kidney transplantation

  1998cited by this paper
• [The prevalence of hepatitis C virus infection].

  1998influential reference
• Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.

  1997cited by this paper
• A cohort study of serum testosterone and hepatocellular carcinoma in Shanghai, China

  1995cited by this paper
• Epidemiology of hepatitis C among veterans with alcoholic liver disease. The VA Cooperative Study Group 275.

  1993cited by this paper
• Elevated serum testosterone levels and risk of hepatocellular carcinoma.

  1993influential reference
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

  year unknowncited by this paper

• China data on the burden of alcohol-associated liver cancer from 1990 to 2021: a systematic analysis from the global burden of disease study 2021.

  2026cites this paper
• Trends in liver cancer rehabilitation needs, disease burden, and attributable risk factors in China, 1990–2021

  2025cites this paper
• Estrogen and viral infection

  2025cites this paper
• Non-invasive assessment of liver fibrosis in MASLD: the need of sex-adjusted scores

  2025cites this paper
• Secondary Cancer after Androgen Deprivation Therapy in Prostate Cancer: A Nationwide Study

  2024cites this paper
• Hepatocellular Carcinoma and Lipid Metabolism: Novel Targets and Therapeutic Strategies.

  2024cites this paper
• Attributable liver cancer deaths and disability-adjusted life years in China and worldwide: profiles and changing trends

  2024cites this paper
• Therapeutic prospects of sex hormone receptor signaling in hormone-responsive cancers.

  2024cites this paper
• The Influence of Urbanization on the Patterns of Hepatocellular Carcinoma Mortality From 1999 to 2020

  2024cites this paper
• Direct‐acting antivirals in women of reproductive age infected with hepatitis C virus

  2024cites this paper
• Sex differences in chronic liver disease and benign liver lesions

  2023cites this paper
• Burden of liver cancer due to hepatitis C from 1990 to 2019 at the global, regional, and national levels

  2023cites this paper
• Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy

  2023influential citation
• Hepatocellular Carcinoma: A Review

  2023cites this paper
• Protective Effect of Daidzein against Diethylnitrosamine/Carbon Tetrachloride-Induced Hepatocellular Carcinoma in Male Rats

  2023cites this paper
• Effect of cirrhosis and hepatitis on the prognosis of liver cancer

  2022cites this paper
• The associations of total testosterone with probable nonalcoholic steatohepatitis and nonalcoholic fatty liver disease fibrotic progression in men with type 2 diabetes: a cross-sectional study

  2022cites this paper
• Estrogen as a key regulator of energy homeostasis and metabolic health.

  2022cites this paper
• The Hepatoprotective and Hepatotoxic Roles of Sex and Sex-Related Hormones

  2022cites this paper
• Intelligent Analysis of Some Factors Accompanying Hepatitis B

  2022cites this paper
• Study of CXCL9-11 gene polymorphisms in liver fibrosis among patients with chronic hepatitis C.

  2021cites this paper
• Toward improving androgen receptor-targeted therapies in male-dominant hepatocellular carcinoma.

  2021cites this paper
• Gender Disparity in Host Responses to Hepatitis B-Related Hepatocellular Carcinoma: A Case Series

  2021cites this paper
• Effect of new oral direct acting antiviral therapy on sexual function in male patients with hepatitis C virus

  2020cites this paper
• Tumor aggression among hepatitis-C related hepatocellular carcinoma patients: an observational study regarding the impact of anti-HCV therapy

  2020cites this paper
• Incidence and risk factors of hepatocellular carcinoma in patients with hepatitis C in China and the United States

  2020cites this paper
• Viral Escape Mechanisms in Hepatitis C and the Clinical Consequences of Persistent Infection

  2020cites this paper
• Testosterone in Men With Chronic Hepatitis C Infection and After Hepatitis C Viral Clearance.

  2019cites this paper
• Molecular Diagnostics in Liver Cancer

  2019cites this paper
• Ancestry and Risk of Hepatic Fibrosis and Inflammation in Patients With HCV Infection.

  2019cites this paper
• Hepatitis B Virus, Hepatitis C Virus, the Microbiome, and Hepatocellular Carcinoma

  2019cites this paper
• Reproductive Endocrinology of Nonalcoholic Fatty Liver Disease.

  2018cites this paper
• Herbal management of hepatocellular carcinoma through cutting the pathways of the common risk factors

  2018cites this paper
• NATURAL HISTORY OF HEPATITIS C

  2018cites this paper
• Association of hyperuricemia with disease severity in chronic hepatitis C patients

  2018cites this paper
• Gender differences in hepatocellular cancer: disparities in nonalcoholic fatty liver disease/steatohepatitis and liver transplantation

  2018cites this paper
• Clinical efficacy of free androgen index, a surrogate hallmark of circulating free testosterone level, in male patients with HCV-related chronic liver disease

  2018cites this paper
• Endocrine disorders associated with hepatitis C virus chronic infection

  2018cites this paper
• AR-Signaling in Human Malignancies: Prostate Cancer and Beyond

  2017cites this paper
• Relationship between sex hormones and RIG-I signaling in peripheral blood mononuclear cells of patients infected with hepatitis C virus.

  2017cites this paper
• An Updated Overview of the Gender-Specific Response to Infection

  2017cites this paper
• Barriers to hepatitis C treatment in the era of direct‐acting anti‐viral agents

  2017cites this paper
• The higher prevalence of truncal obesity and diabetes in American than Chinese patients with chronic hepatitis C might contribute to more rapid progression to advanced liver disease

  2017cites this paper
• Exemestane Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells and Promoting the Secretion of Interleukin 10

  2017cites this paper
• Male Hypogonadism and Liver Disease

  2017cites this paper
• 17,β‐estradiol inhibits hepatitis C virus mainly by interference with the release phase of its life cycle

  2016cites this paper
• Diagnostic Value of Serum Syndecan-1 in Hepatocellular Carcinoma Associated with Hepatitis C virus in Egyptian Patients

  2016cites this paper
• Epidemiological Trends in NASH as a Cause for Liver Transplant

  2016cites this paper
• Hepatocellular Carcinoma and Hepatitis C Virus

  2016cites this paper
• Hepatitis C virus infection and thyroid autoimmune disorders: A model of interactions between the host and the environment.

  2016cites this paper
• Hepatocellular carcinoma: a review

  2016cites this paper
• Acquired Hypogonadotropic Hypogonadism (AHH) in Thalassaemia Major Patients: An Underdiagnosed Condition?

  2016cites this paper
• Role of Non-hepatic Medical Comorbidity and Functional Limitations in Predicting Mortality in Patients with HCV

  2016cites this paper
• Associations Between Sex Hormone Levels and Periodontitis in Men: Results From NHANES III.

  2015cites this paper
• Natural History of Hepatitis C.

  2015cites this paper
• Coffee and Caffeine Are Associated With Decreased Risk of Advanced Hepatic Fibrosis Among Patients With Hepatitis C.

  2015cites this paper
• Female Sex Hormones Pattern and Its Relation to Disease Severity and Treatment in Pre- and Postmenopausal Patients with Chronic Hepatitis C Virus (Genotype 4) Infection

  2015cites this paper
• Association Between Endogenous Sex Hormones and Liver Fat in a Multiethnic Study of Atherosclerosis.

  2015cites this paper
• Genetic Variants in Interleukin-28B Are Associated with Diabetes and Diabetes-Related Complications in Patients with Chronic Hepatitis C Virus Infection

  2015cites this paper
• Gender differences in liver diseases and their linkage to androgen / androgen receptor There are four major liver diseases associated with gender

  2014cites this paper
• Androgen receptor signaling in hepatocellular carcinoma and pancreatic cancers.

  2014cites this paper
• Sex hormone pathway gene polymorphisms are associated with risk of advanced hepatitis C-related liver disease in males.

  2014cites this paper
• Many patients with interleukin 28B genotypes associated with response to therapy are ineligible for treatment because of comorbidities.

  2014cites this paper
• Aflatoxin Exposure May Not Play a Role in Liver Cancer Development in Mongolia

  2014cites this paper
• Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis.

  2014cites this paper
• Hospitalizations due to hepatitis C in Los Angeles County, 2007–2009: case characteristics and factors associated with mortality

  2013cites this paper
• WNT Signaling Pathway Gene Polymorphisms and Risk of Hepatic Fibrosis and Inflammation in HCV-Infected Patients

  2013cites this paper
• Individualized hepatocellular carcinoma risk: the challenges for designing successful chemoprevention strategies.

  2013cites this paper
• Dietary Fructose Intake and Severity of Liver Disease in Hepatitis C Virus-infected Patients

  2013cites this paper
• Hepatocellular carcinoma: the rising tide from east to west—a review of epidemiology, screening and tumor markers

  2013cites this paper
• Reproductive Status Is Associated with the Severity of Fibrosis in Women with Hepatitis C

  2012cites this paper
• In reference to higher serum testosterone is associated with increased risk of advanced hepatitis c‐related liver disease in males

  2012cites this paper
• Epidemiology of viral hepatitis and hepatocellular carcinoma.

  2012cites this paper
• Finasteride and Methadone Use and Risk of Advanced Hepatitis C Related Liver Disease

  2012cites this paper
• Racial Differences in the Association Between Adiposity Measures and the Risk of Hepatitis C-related Liver Disease

  2012cites this paper
• Natural history of HCV infection

  2012cites this paper
• Metabolic oxidation controls the hepatic stem cells (HpSCs) fate and the hepatic lineage organization in physiologic and pathologic conditions

  2012cites this paper
• RE: Higher serum testosterone is associated with increased risk of advanced hepatitis C‐related liver disease in males

  2012cites this paper
• Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: proof of concept and first application in a large population.

  2012influential citation
• Mediterranean Journal of Hematology and Infectious Diseases Acquired Hypogonadotropic Hypogonadism (ahh) in Thalassaemia Major Patients: an Underdiagnosed Condition? Liver Functions and Screening for Hepatitis C Virus Seropositivity (hcvab and Hcv-rna) Were Performed. Iron Status Was Assessed by Mea

  year unknowncites this paper